These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24408014)

  • 1. Gastrokine-2 is downregulated in gastric cancer and its restoration suppresses gastric tumorigenesis and cancer metastasis.
    Dai J; Zhang N; Wang J; Chen M; Chen J
    Tumour Biol; 2014 May; 35(5):4199-207. PubMed ID: 24408014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthesis of gastrokine-2 in the human gastric mucosa: restricted spatial expression along the antral gland axis and differential interaction with TFF1, TFF2 and mucins.
    Kouznetsova I; Laubinger W; Kalbacher H; Kalinski T; Meyer F; Roessner A; Hoffmann W
    Cell Physiol Biochem; 2007; 20(6):899-908. PubMed ID: 17982272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterodimeric interaction between GKN2 and TFF1 entails synergistic antiproliferative and pro-apoptotic effects on gastric cancer cells.
    Kim O; Yoon JH; Choi WS; Ashktorab H; Smoot DT; Nam SW; Lee JY; Park WS
    Gastric Cancer; 2017 Sep; 20(5):772-783. PubMed ID: 28150071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of gastrokine 1 and the trefoil factor interacting protein TFIZ1/GKN2 in gastric cancer: influence of tumor histology and relationship to prognosis.
    Moss SF; Lee JW; Sabo E; Rubin AK; Rommel J; Westley BR; May FE; Gao J; Meitner PA; Tavares R; Resnick MB
    Clin Cancer Res; 2008 Jul; 14(13):4161-7. PubMed ID: 18593995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrokine 2 Regulates the Antitumor Effect of JAK2/STAT3 Pathway in Gastric Cancer.
    Zhou Y; Xu S; Liu J; Zhu Y; Zhu Y; Li W; Ling H
    Evid Based Complement Alternat Med; 2021; 2021():1343808. PubMed ID: 34381519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel gastrokine, Gkn3, marks gastric atrophy and shows evidence of adaptive gene loss in humans.
    Menheniott TR; Peterson AJ; O'Connor L; Lee KS; Kalantzis A; Kondova I; Bontrop RE; Bell KM; Giraud AS
    Gastroenterology; 2010 May; 138(5):1823-35. PubMed ID: 20138039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK6 Homeobox 2 Regulated Gastrokin-2 Suppresses Gastric Cancer Cell Proliferation and Invasion via Akt Signaling Pathway.
    Dai J; Peng T; Yu X
    Cell Biochem Biophys; 2021 Mar; 79(1):123-131. PubMed ID: 33009998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrokine-2 suppresses epithelial mesenchymal transition through PI3K/AKT/GSK3β signaling in gastric cancer.
    Dai J; Qian C; Su M; Chen M; Chen J
    Tumour Biol; 2016 Sep; 37(9):12403-12410. PubMed ID: 27323966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine regulation of the trefoil factor family binding protein GKN2 (GDDR/TFIZ1/blottin) in human gastrointestinal epithelial cells.
    Baus-Loncar M; Lubka M; Pusch CM; Otto WR; Poulsom R; Blin N
    Cell Physiol Biochem; 2007; 20(1-4):193-204. PubMed ID: 17595528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of gastrokine-2 drives premalignant gastric inflammation and tumor progression.
    Menheniott TR; O'Connor L; Chionh YT; Däbritz J; Scurr M; Rollo BN; Ng GZ; Jacobs S; Catubig A; Kurklu B; Mercer S; Minamoto T; Ong DE; Ferrero RL; Fox JG; Wang TC; Sutton P; Judd LM; Giraud AS
    J Clin Invest; 2016 Apr; 126(4):1383-400. PubMed ID: 26974160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GKN2 promotes oxidative stress-induced gastric cancer cell apoptosis via the Hsc70 pathway.
    Zhang Z; Xue H; Dong Y; Zhang J; Pan Y; Shi L; Xiong P; Zhu J; Li W; Zheng W; Liu J; Du J
    J Exp Clin Cancer Res; 2019 Aug; 38(1):338. PubMed ID: 31382983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of trefoil factor 1 in gastric cancer and relationship between trefoil factor 1 and gastrokine 1.
    Mao W; Chen J; Peng TL; Yin XF; Chen LZ; Chen MH
    Oncol Rep; 2012 Oct; 28(4):1257-62. PubMed ID: 22842654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trefoil factor 1 and gastrokine 2 inhibit
    Liu W; Li J; Zhang D; Chen B; Wang X; Zhang X; Xue L
    Oncol Lett; 2020 Dec; 20(6):318. PubMed ID: 33133254
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues.
    Leung WK; Yu J; Chan FK; To KF; Chan MW; Ebert MP; Ng EK; Chung SC; Malfertheiner P; Sung JJ
    J Pathol; 2002 Aug; 197(5):582-8. PubMed ID: 12210076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori infection promotes methylation and silencing of trefoil factor 2, leading to gastric tumor development in mice and humans.
    Peterson AJ; Menheniott TR; O'Connor L; Walduck AK; Fox JG; Kawakami K; Minamoto T; Ong EK; Wang TC; Judd LM; Giraud AS
    Gastroenterology; 2010 Dec; 139(6):2005-17. PubMed ID: 20801119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trefoil factor family 2 expression inhibits gastric cancer cell growth and invasion in vitro via interactions with the transcription factor Sp3.
    Cai Y; Yi M; Chen D; Liu J; Guleng B; Ren J; Shi H
    Int J Mol Med; 2016 Nov; 38(5):1474-1480. PubMed ID: 27668303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GKN2 increases apoptosis, reduces the proliferation and invasion ability of gastric cancer cells through down-regulating the JAK/STAT signaling pathway.
    Ouyang J; Pan X; Lin H; Hu Z; Xiao P; Hu H
    Am J Transl Res; 2017; 9(2):803-811. PubMed ID: 28337309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-level gastrokine 2 promoted progress of NSCLC and as a potential biomarker.
    Yang X; Shi W; Zhou H; Huang X; Hu L; Feng J; Wang Y
    J Clin Lab Anal; 2022 Feb; 36(2):e24213. PubMed ID: 34970791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
    Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
    Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GKN2 contributes to the homeostasis of gastric mucosa by inhibiting GKN1 activity.
    Kim O; Yoon JH; Choi WS; Ashktorab H; Smoot DT; Nam SW; Lee JY; Park WS
    J Cell Physiol; 2014 Jun; 229(6):762-71. PubMed ID: 24151046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.